Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells
Marco Donia(University of Copenhagen), Ferdinando Nicoletti(University of Catania), María Clorinda Mazzarino(University of Catania), Marinella Coco(University of Catania), Paola Castrogiovanni(University of Catania), Rosa Imbesi(University of Catania), Alfredo Amoroso(University of Catania), Katia Mangano(University of Catania), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano)
Cited by 77
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508